As shown in Fig. 3C and D, patients with low levels of CXCL13 and galectin-9 were significantly associated with longer PFS in CLL (p = 0.0018, p = 0.0014, respectively). This evidence concerns the gene CXCL13 and B-cell chronic lymphocytic leukemia.